Patents by Inventor Kendall Wayne King

Kendall Wayne King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses
    Patent number: 12350328
    Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines. In one aspect, the invention relates to a composition comprising a multivalent equine live-attenuated influenza vaccine comprising a first live-attenuated influenza virus expressing one or more antigens of a clade 1 H3N8 equine influenza virus; and a second live-attenuated influenza virus expressing one or more antigens of a clade 2 H3N8 equine influenza virus, wherein the second live-attenuated influenza virus expresses HA, NA, or a combination thereof of A/equine/Lancashire/1/2016 H3N8.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: July 8, 2025
    Assignees: University of Rochester, UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, ZOETIS SERVICES LLC
    Inventors: Luis Martinez-Sobrido, Thomas Chambers, Kendall Wayne King
  • Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses
    Publication number: 20220133877
    Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines. In one aspect, the invention relates to a composition comprising a multivalent equine live-attenuated influenza vaccine comprising a first live-attenuated influenza virus expressing one or more antigens of a clade 1 H3N8 equine influenza virus; and a second live-attenuated influenza virus expressing one or more antigens of a clade 2 H3N8 equine influenza virus, wherein the second live-attenuated influenza virus expresses HA, NA, or a combination thereof of A/equine/Lancashire/1/2016 H3N8.
    Type: Application
    Filed: February 27, 2020
    Publication date: May 5, 2022
    Inventors: Luis Martinez-Sobrido, Thomas Chambers, Kendall Wayne King
  • Vaccine for periodontal disease
    Patent number: 7468185
    Abstract: The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: December 23, 2008
    Assignee: Pfizer Inc.
    Inventors: John Morgan Hardham, Kendall Wayne King, Rajendra Krishnan, Kimberly Jean Dreier, David Ross McGavin
  • Vaccine For Periodontal Disease
    Publication number: 20080311151
    Abstract: The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease. In addition, methods for assessing the efficacy of a vaccine against periodontal diseases in an animal are provided.
    Type: Application
    Filed: May 12, 2008
    Publication date: December 18, 2008
    Applicants: PFIZER, INC., PFIZER PRODUCTS, INC.
    Inventors: John Morgan Hardham, Kendall Wayne King, Rajendra Krishnan, Kimberly Jean Dreier, David Ross McGavin, John David Haworth
  • Vaccine for periodontal disease
    Patent number: 7378101
    Abstract: The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease. In addition, methods for assessing the efficacy of a vaccine against periodontal diseases in an animal are provided.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: May 27, 2008
    Assignees: Pfizer, Inc., Pfizer Products, Inc.
    Inventors: John Morgan Hardham, Kendall Wayne King, Rajendra Krishnan, Kimberly Jean Dreier, David Ross McGavin, John David Haworth
  • Therapeutic compositions for treating infection by Lawsonia spp.
    Patent number: 6846487
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: January 25, 2005
    Assignees: Pfizer Inc., Agriculture Victoria Services Pty Ltd., Austrailian Pork Limited
    Inventors: Everett Lee Rosey, Kendall Wayne King, Robert Trygve Good, Richard Anthony Strugnell
  • Vaccine for periodontal disease
    Publication number: 20030228328
    Abstract: The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease.
    Type: Application
    Filed: December 18, 2002
    Publication date: December 11, 2003
    Applicant: Pfizer Inc.
    Inventors: John Morgan Hardham, Kendall Wayne King, Rajendra Krishnan, Kimberly J. Dreier, David R. McGavin
  • Novel therapeutic compositions for treating infection by Lawsonia spp.
    Publication number: 20030103999
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides.
    Type: Application
    Filed: November 9, 2001
    Publication date: June 5, 2003
    Inventors: Everett Lee Rosey, Kendall Wayne King, Robert Trygve Good, Richard Anthony Strugnell